Statins (lipid-lowering drugs) are among the most widely prescribed medications, because they markedly reduce the incidence of major cardiovascular events by lowering LDL-cholesterol. However, muscle symptoms such as fatigue, myalgia, cramps, stiffness and tenderness are expected to occur in 15-20% of statin users, which may lead to nonadherence to statin treatment. Multiple studies show that statins are linked to mitochondrial disturbances, which may be the cause of the muscle symptoms.This year the research during the Four Days Marches of Maria Hopman and her team, which takes place for the 12th year now, focuses on statin users who walk the Nijmegen marches. The Four Days Marches are an unique setting to examine the effects of intense exercise on muscle functioning. One hundred participants are included in this study to gain more insight into the influence of statins on muscle performance. Statin users with muscle complaints will be compared to statin users without complaints and non-statin users. Prior and during the Four Days Marches extensive measurements are performed to assess muscle function, muscle damage, mitochondrial function, pain and fatigue.
More information: www.vierdaagseonderzoek.nl
Maria Hopman is member of research theme Mitochondrial diseases.
Related news items
Step-up approach vs open necrosectomy for necrotizing pancreatitis18 April 2019
Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.read more
Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients18 April 2019
In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.read more
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more